Search Tag: PDAC

2025 21 Jul

  Pancreatic ductal adenocarcinoma (PDAC) is characterised by high malignancy and a notably poor prognosis, with early lymph node metastasis (LNM) serving as a key prognostic factor. Current clinical guidelines recommend dissection of at least 15 lymph nodes during surgery, though survival remains low, especially in patients with extensive dissection...Read more

2025 25 Apr

Pancreatic ductal adenocarcinoma (PDAC) remains among the most lethal cancers globally due to its frequent late diagnosis and limited treatment options. While surgical resection offers the only curative potential, few patients qualify for this intervention at the time of diagnosis. Early detection through imaging is therefore paramount. Radiologists...Read more